|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |review |
 |
- Efficacy of ZDV in
decreasing perinatal transmission not related primarily to Rx-induced
reduction in maternal viral load but to presence of systemic antiretroviral
drug levels in neonate @ time of delivery - Intense exposure to HIV in maternal genital secretions during delivery ZDV administration intrapartum & to newborn provides pre- and post-exposure prophylaxis |